Issued Patents All Time
Showing 1–13 of 13 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12421238 | Selective dihydropyrrolopyrimidine JAK2 inhibitors | Nongnong WEI, Hua Jin, Yongyong Zheng, Meihua HUANG | 2025-09-23 |
| 12247015 | 3-amino-4H-benzo[e][1,2,4]thiadiazine 1,1-dioxide derivatives as inhibitors of MRGX2 | Simone Bigi, Alison L. Chambers, Tony S. Gibson, Jason C. Pickens, Steve Swann +4 more | 2025-03-11 |
| 12109198 | Macrocyclic azolopyridine derivatives as EED and PRC2 modulators | Ivan Viktorovich Efremov, Steven Kazmirski, Qingyi Li, Lorin A. Thompson, III, Owen Brendan Wallace +2 more | 2024-10-08 |
| 11814405 | Pyridine sulfonamide phosphate compound, preparation method therefor, and use thereof | Nongnong WEI, Hua Jin, Yongyong Zheng, Meihua HUANG | 2023-11-14 |
| 11725020 | Prodrugs of a CDK inhibitor for treating cancers | Jiasheng LU, Jiamin GU, Gang Chen, Xiaolin Zhang, Xianqi Kong | 2023-08-15 |
| 11590111 | Macrocyclic azolopyridine derivatives as EED and PRC2 modulators | Ivan Viktorovich Efremov, Steven Kazmirski, Qingyi Li, Lorin A. Thompson, III, Owen Brendan Wallace +2 more | 2023-02-28 |
| 11530234 | CD73 inhibitors and pharmaceutical uses thereof | Jiasheng LU, Jiamin GU, Gang Chen, Qiguo ZHANG, Xuli Wang +3 more | 2022-12-20 |
| 11225497 | Prodrugs of a CDK inhibitor for treating cancers | Jiasheng LU, Jiamin GU, Gang Chen, Xiaolin Zhang, Xianqi Kong | 2022-01-18 |
| 10973805 | Macrocyclic azolopyridine derivatives as EED and PRC2 modulators | Ivan Viktorovich Efremov, Steven Kazmirski, Qingyi Li, Lorin A. Thompson, III, Owen Brendan Wallace +2 more | 2021-04-13 |
| 10881681 | CD73 inhibitors and pharmaceutical uses thereof | Jiasheng LU, Jiamin GU, Dongdong Wu, Gang Chen, Chengyong Sun +4 more | 2021-01-05 |
| 10464927 | 2,4-disubstituted pyrimidines as CDK inhibitors | Yongyong Zheng, Hua Jin, Meihua HUANG, Xin Meng | 2019-11-05 |
| 10351578 | Heterocyclic-substituted pyridinopyrimidinone derivative as CDK inhibitor and use thereof | Yongyong Zheng, Hua Jin, Meihua HUANG, Xin Meng | 2019-07-16 |
| 9695175 | Highly selective c-Met inhibitors as anticancer agents | Boyu Zhong, Chuan Shih, Hongbin Yuan | 2017-07-04 |